Development and validation of an integrated model for the diagnosis of liver cirrhosis with portal vein thrombosis combined with endoscopic characters and blood biochemistry data: a retrospective propensity score matching (PSM) cohort study

Development and validation of an integrated model for the diagnosis of liver cirrhosis with portal vein thrombosis combined with endoscopic characters and blood biochemistry data: a retrospective propensity score matching (PSM) cohort study

Background Liver cirrhosis complicated by portal vein thrombosis (PVT) is a fatal complication with no specific manifestations but often misdiagnosed, it crucially increases the mortality worldwide. This study aimed to identify risk factors and establish a predictive model for diagnosis of venous th...

Bibliografski detalji
Glavni autori:	Jie Yang, Xu Zhang, Jia Chen, Xianghong Hou, Minghong Shi, Longlong Yin, Longchun Hua, Cheng Wang, Xiaolong Han, Shuyan Zhao, Guolan Kang, Ping Mai, Rui Jiang, Hongwei Tian
Format:	Članak
Jezik:	English
Izdano:	Taylor & Francis Group 2025-12-01
Serija:	Annals of Medicine
Teme:	Liver cirrhosis portal vein thrombosis endoscopic prediction model
Online pristup:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2457521

Slični predmeti

Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis
od: Roberto Cangemi, i dr.
Izdano: (2024-01-01)

Portal vein thrombosis in cirrhosis: A literature review
od: Swathi Prakash, i dr.
Izdano: (2023-04-01)

Portal vein thrombosis in patients with liver cirrhosis
od: Savić Željka, i dr.
Izdano: (2024-01-01)

Transient portal vein thrombosis in liver cirrhosis
od: Xingshun Qi, i dr.
Izdano: (2018-06-01)

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
od: Hyeyoung Yang, i dr.
Izdano: (2016-12-01)

The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study
od: Zhiji Chen, i dr.
Izdano: (2021-06-01)

Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome
od: Shunichiro Fujiyama, i dr.
Izdano: (2017-10-01)

The Effect of Anticoagulant in Patients with Cirrhosis Associated with Acute Portal Vein Thrombosis
od: Hoon Gil Jo, i dr.
Izdano: (2021-09-01)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
od: Tsuyoshi Suda, i dr.
Izdano: (2020-09-01)

Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis
od: Tomoko Tadokoro, i dr.
Izdano: (2024-05-01)

Portal vein thrombosis in liver cirrhosis: An updated overview
od: Zhinian Wu, i dr.
Izdano: (2023-06-01)

MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
od: Maria Anna Guardascione, i dr.
Izdano: (2009-11-01)

MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
od: Lucio Amitrano, i dr.
Izdano: (2009-11-01)

Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study
od: Zhiqi Zhang, i dr.
Izdano: (2023-01-01)

Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification
od: Zeeshan A Wani, i dr.
Izdano: (2015-01-01)

Is serum apelin related to portal hemodynamics in patients with liver cirrhosis?
od: Ashraf G Dala, i dr.
Izdano: (2018-01-01)

Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis
od: Haonan Zhou, i dr.
Izdano: (2023-09-01)

Analysis of related factors of portal vein thrombosis in liver cirrhosis
od: Xiaotong Xu, i dr.
Izdano: (2023-01-01)

Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study
od: Yali Shi, i dr.
Izdano: (2024-07-01)

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
od: Takehiro Hayashi, i dr.
Izdano: (2019-12-01)

A new model of portal vein thrombosis in rats with cirrhosis induced by partial portal vein ligation plus carbon tetrachloride and intervened with rivaroxaban
od: Yanan Guo, i dr.
Izdano: (2024-05-01)

Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis
od: Xin-yu Huang, i dr.
Izdano: (2023-10-01)

Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis
od: D V Garbuzenko
Izdano: (2016-02-01)

Study of Factors Associated with Concomitant Gastrointestinal Bleeding in Patients with Portal Vein Thrombosis in Liver Cirrhosis
od: DONG Wendi, YANG Jiani, ZHU Jie, QUAN Yujie, ZHANG Jinjing, LIU Yan, ZHANG Hairong
Izdano: (2024-02-01)

A novel potential mechanism for the development of portal vein thrombosis in cirrhosis based on portal hemodynamics
od: Yuling Yan, i dr.
Izdano: (2022-12-01)

Surgical treatment of portal hypertension complications in patients with liver cirrhosis
od: V. M. Durleshter, i dr.
Izdano: (2022-09-01)

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
od: Chandana B. Herath, i dr.
Izdano: (2022-03-01)

Non Cirrhotic Portal Vein Thrombosis: Diagnostic and Therapeutic Challenge
od: Syifa Mustika, i dr.
Izdano: (2021-05-01)

Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients
od: Ji Min Han, i dr.
Izdano: (2023-02-01)

Effect of Propranolol on Portal Pressure and Systemic Hemodynamics in Patients with Liver Cirrhosis and Portal Hypertension: A Prospective Study
Izdano: (2007-12-01)

Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis
od: Hitoshi Maruyama, i dr.
Izdano: (2022-12-01)

Elastography in the diagnosis of portal hypertension in patients with liver cirrhosis
od: E O Liusina, i dr.
Izdano: (2017-02-01)

Management of Nonmalignant Portal Vein Thrombosis in Cirrhosis
od: Francisco Capinha, i dr.
Izdano: (2023-10-01)

Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
od: D. V. Garbuzenko
Izdano: (2018-11-01)

Portal Vein Thrombosis in Liver Cirrhosis. Part 1: Epidemiology, Pathogenesis, Clinic, Diag-nosis, Impact on Prognosis
od: A. V. Yagoda, i dr.
Izdano: (2024-06-01)

High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study
od: Bo Gao, i dr.
Izdano: (2019-03-01)

Endothelins and liver cirrhosis
od: Necati Örmeci
Izdano: (2022-06-01)

Portal Vein Thrombosis in Liver Cirrhosis. Part 2: Treatment, Primary and Secondary Prevention
od: A. V. Yagoda, i dr.
Izdano: (2024-08-01)

Correlation of Upper and Lower Endoscopic Changes in Patients with Liver Cirrhosis and Portal Hypertension
od: Mohamed Mohamed Salem, i dr.
Izdano: (2022-05-01)

Platelet-derived TGF-β1 is related to portal vein thrombosis in cirrhosis by promoting hypercoagulability and endothelial dysfunction
od: Siyu Jiang, i dr.
Izdano: (2022-09-01)